Literature DB >> 1934242

Monitored medico-surgical approach to the treatment of cystic hydatidosis.

G N Awar1, R M Matossian, H Radwan, G A Meshefedjian.   

Abstract

Significant improvements in the health of patients with chronic multifocal abdominal hydatidosis, leading to recovery, have been observed after combined medico-surgical treatment. The benefits of massive surgical removal of cysts, accompanied by effective doses of albendazole, were assessed by the clinical, radiological, and immunological responses of individual patients. Variations in the levels of specific classes of immunoglobulins and circulating immunocomplexes provided additional measures of the state of host response and the persistence of parasitic activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934242      PMCID: PMC2393230     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  13 in total

1.  Albendazole in the conservative management of multiple hydatid disease.

Authors:  B Golematis; G Lakiotis; P Persidou-Golemati; G Bonatsos
Journal:  Mt Sinai J Med       Date:  1989-01

2.  Optimal timing of post-operative albendazole prophylaxis in E. granulosus.

Authors:  D L Morris; D H Taylor
Journal:  Ann Trop Med Parasitol       Date:  1988-02

3.  Detection of specific circulating antigen, immune complexes and antibodies in human hydatidosis from Turkana (Kenya) and Great Britain, by enzyme-immunoassay.

Authors:  P S Craig
Journal:  Parasite Immunol       Date:  1986-03       Impact factor: 2.280

4.  Chemotherapy of Echinococcus infection in man with albendazole.

Authors:  R J Horton
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jan-Feb       Impact factor: 2.184

5.  Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis.

Authors:  A Davis; Z S Pawlowski; H Dixon
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

6.  Hydatid disease: research and control in Turkana, III. Albendazole in the treatment of inoperable hydatid disease in Kenya--a report on 12 cases.

Authors:  G B Okelo
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

Review 7.  Excretory-secretory products of helminth parasites: effects on host immune responses.

Authors:  M W Lightowlers; M D Rickard
Journal:  Parasitology       Date:  1988       Impact factor: 3.234

8.  Pre-operative albendazole therapy for hydatid cyst.

Authors:  D L Morris
Journal:  Br J Surg       Date:  1987-09       Impact factor: 6.939

9.  Albendazole as a potential treatment for human hydatidosis.

Authors:  A G Saimot; A Meulemans; A C Cremieux; M D Giovanangeli; J M Hay; B Delaitre; J P Coulaud
Journal:  Lancet       Date:  1983-09-17       Impact factor: 79.321

10.  Effect of plasma mebendazole concentrations in the treatment of human echinococcosis.

Authors:  W Woodtli; J Bircher; F Witassek; J Eckert; B Wüthrich; R W Ammann
Journal:  Am J Trop Med Hyg       Date:  1985-07       Impact factor: 2.345

View more
  4 in total

1.  EXTENSIVE ABDOMINAL HYDATID DISEASE.

Authors:  P R Rao; A S Sandhu
Journal:  Med J Armed Forces India       Date:  2017-06-26

2.  Oxfendazole treatment of sheep with naturally acquired hydatid disease.

Authors:  E L Dueger; P L Moro; R H Gilman
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  Alveolar hydatid disease. Review of the surgical experience in 42 cases of active disease among Alaskan Eskimos.

Authors:  J F Wilson; R L Rausch; F R Wilson
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

4.  [An unusual form of presentation of hepatic hydatid cyst: intraperitoneal rupture, a report of 5 cases].

Authors:  Mohamed Rami; Khalid Khattala; Abdelhalim Mahmoudi; Aziz El Madi; My Afifi Abderrahmane; Youssef Bouabdallah
Journal:  Pan Afr Med J       Date:  2011-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.